Education
About Us
Working with TipRanks
Follow Us
Cansortium (CNTMF)
OTHER OTC:CNTMF
CNTMF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.04 - $0.19
Previous CloseN/A
Volume189.91K
Average Volume (3M)185.31K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)113.50M
Price to Earnings (P/E)―
Beta0.20
Next Earnings
Sep 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding449,337,300
10 Day Avg. Volume191,285
30 Day Avg. Volume185,306
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cansortium News
PremiumCompany Announcements
FLUENT Corp Reports Q1 2025 Financial Results
PremiumCompany Announcements
Cansortium’s Earnings Call: Record Revenue Amid Challenges
PremiumCompany Announcements
FLUENT Corp. Reports Record Revenue and Strategic Expansion
PremiumCompany Announcements
Cansortium Inc. Rebrands as FLUENT Corp. Following Strategic Transaction
PremiumCompany Announcements
Cansortium Expands with RIV Capital AcquisitionOptions Prices
Currently, No data available
---
Ownership Overview
49.51% Insiders
0.06% Mutual Funds
2.55% Other Institutional Investors
45.42% Public Companies and Individual Investors
CNTMF FAQ
What was Cansortium’s price range in the past 12 months?
Cansortium lowest stock price was $0.04 and its highest was $0.19 in the past 12 months.
What is Cansortium’s market cap?
Currently, no data Available
When is Cansortium’s upcoming earnings report date?
Cansortium’s upcoming earnings report date is Sep 01, 2025 which is in 44 days.
How were Cansortium’s earnings last quarter?
Currently, no data Available
Is Cansortium overvalued?
According to Wall Street analysts Cansortium’s price is currently Overvalued.
Does Cansortium pay dividends?
Cansortium does not currently pay dividends.
What is Cansortium’s EPS estimate?
Cansortium’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cansortium have?
Cansortium has 449,337,300 shares outstanding.
What happened to Cansortium’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cansortium?
Currently, no hedge funds are holding shares in CNTMF
Company Description
Cansortium
Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. The company engages in the cultivation, processing, retail, and distribution activities. Its medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls, cartridges, and edibles. The company provides its products under the Fluent brand name. As of August 20, 2021, it operated 28 dispensaries. Cansortium Inc. was incorporated in 2018 and is headquartered in Miami, Florida.
CNTMF Company Deck
CNTMF Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements such as record-breaking annual revenue, strategic acquisitions, and expansion efforts, demonstrating strong growth and operational resilience. However, challenges remain with fourth quarter revenue declines and decreased profit margins, primarily due to market pressures in Florida.Read More>Technical Analysis
Quantum Biopharma
―
Ayr Wellness
―
Green Thumb Industries
―
MediPharm Labs
―
Trulieve Cannabis
―